Hisao Nakajima
Präsident bei SNBL Clinical Pharmacology Center, Inc.
Ursprung des Netzwerks ersten Grades von Hisao Nakajima
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
SNBL Clinical Pharmacology Center, Inc.
4
| Private Company | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Hisao Nakajima
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member Comptroller/Controller/Auditor Director of Finance/CFO | |
SNBL USA Ltd.
 SNBL USA Ltd. Medical/Nursing ServicesHealth Services SNBL USA Ltd. provides general toxicology, acute radiation syndrome, apheresis, CNS drug delivery, immunohistochemistry, tissue cross reactivity and biological services. The company is headquartered in Everrett, WA. | Medical/Nursing Services | Chairman Director/Board Member Director/Board Member | |
Medipolis Medical Research Institute
 Medipolis Medical Research Institute Medical/Nursing ServicesHealth Services Medipolis Medical Research Institute offers proton beam cancer treatment. The company was founded on March 2006 and is headquartered in Ibusuki, Japan. | Medical/Nursing Services | Chairman Director/Board Member | |
| SNBL Europe, Ltd. | Chief Executive Officer | ||
| RKE Co., Ltd. | Chairman | ||
SNBL China, Ltd.
 SNBL China, Ltd. Agricultural Commodities/MillingProcess Industries Part of Pharmaron Beijing Co., Ltd., SNBL China, Ltd. breeds and sells laboratory animals. The company is based in Zhaoqing, China. The Chinese company was founded in 2003. The CEO is Yan Wei Liu. SNBL China was acquired by Pharmaron Beijing Co., Ltd. from Shin Nippon Biomedical Laboratories, Ltd. on April 30, 2021. | Agricultural Commodities/Milling | Chairman | |
Pharmaron CPC, Inc.
 Pharmaron CPC, Inc. BiotechnologyHealth Technology Pharmaron CPC, Inc. provides pharmaceutical research services. It focuses on Phase I and IIa clinical pharmacology research and clinical trials, includes first-in-human studies and adaptive design, neurology, infectious diseases and vaccine development, and ethno bridging. The company was founded in 2005 and is headquartered in Baltimore, MD. | Biotechnology | Chairman | |
| Translational Research USA, Inc. | Chief Executive Officer | ||
| Shin Nippon Biomedical Laboratories (Cambodia) Ltd. | Director/Board Member | ||
Shin Nippon Biomedical Laboratories India Pvt Ltd.
 Shin Nippon Biomedical Laboratories India Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Shin Nippon Biomedical Laboratories, Ltd., Shin Nippon Biomedical Laboratories India Pvt Ltd. is an Indian company that provides clinical, drug research and development services. The company is based in Bangalore, India and was founded in 2007. | Miscellaneous Commercial Services | Director/Board Member | |
| Ruika Therapeutics, Inc. | Chairman | ||
| Saifuku Gakuen | Chairman | ||
| SATSUMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
PPD-SNBL KK
 PPD-SNBL KK Miscellaneous Commercial ServicesCommercial Services Part of Thermo Fisher Scientific, Inc., PPD-SNBL KK is a Japanese company that provides clinical research services. The company is based in Tokyo, Japan. | Miscellaneous Commercial Services | President Director of Finance/CFO |
Statistik
International
| Japan | 6 |
| Vereinigte Staaten | 6 |
| Vereinigtes Königreich | 2 |
| China | 2 |
| Indien | 2 |
Sektoral
| Commercial Services | 4 |
| Health Services | 3 |
| Health Technology | 3 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 13 |
| Chairman | 9 |
| Chief Executive Officer | 4 |
| President | 4 |
| Corporate Officer/Principal | 2 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Ryoichi Nagata | 15 |
| Hidenobu Samejima | 4 |
| Toshihiko Seki | 4 |
| Ken Mori | 2 |
- Börse
- Insiders
- Hisao Nakajima
- Unternehmensverbindungen
